LCZ696 (Sacubitril/Valsartan)

LCZ696 (Sacubitril/Valsartan)

First and foremost, this was a non-pre-specified post-hoc analysis with the inherent limitations and potential for unrecognized bias. [...]which patients in stable condition should be switched from their current renin-angiotensin-aldosterone system inhibitors to LCZ696?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-11, Vol.66 (19), p.2072-2074
1. Verfasser: Dec, G. William, MD
Format: Artikel
Sprache:eng
Schlagworte:
Alzheimer's disease
Biomarkers
Cardiology
Cardiovascular
Clinical medicine
Confidence intervals
Drug dosages
Enzymes
Heart attacks
Heart failure
Hospitalization
Internal Medicine
Medical prognosis
Mortality
Peptides
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:First and foremost, this was a non-pre-specified post-hoc analysis with the inherent limitations and potential for unrecognized bias. [...]which patients in stable condition should be switched from their current renin-angiotensin-aldosterone system inhibitors to LCZ696?
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.877